Skip to main content

ZIPRASIDONE MESYLATE

NDC 51662-1564 · HF Acquisition Co LLC, DBA HealthFirst

Generic nameZIPRASIDONE MESYLATE
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAMUSCULAR
Active ingredient(s)ZIPRASIDONE MESYLATE
Strength20 mg/mL
Pharmacologic classAtypical Antipsychotic [EPC]
Marketing categoryANDA

Packages

51662-1564-3 — 10 POUCH in 1 CASE (51662-1564-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1564-2) / 5 mL in 1 VIAL, SINGLE-DOSE

Billed under HCPCS

J3486 — Injection, ziprasidone mesylate, 10 mg Medicare Part B payment limit (ASP + 6%): $5.94

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0049-3920 — ziprasidone mesylate, 43598-061 — ziprasidone mesylate, 43598-848 — ziprasidone mesylate, 58151-137 — ziprasidone mesylate, 68083-340 — ziprasidone mesylate, 72205-205 — ziprasidone mesylate, 72266-160 — Ziprasidone Mesylate, 82449-004 — ziprasidone mesylate

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources